IL17A and systemic lupus erythematosus: Serum levels of IL-21 and IL-22 have also been found to increase with symptom severity in patients with SLE.210 IL-17 can modulate the pathological processes of SLE in humans through the combined action of other cytokines associated with IL-17-producing cells.210